Thermo Fisher Launches Molecular Diagnostic System for Lung Transplant Rejection Assessment
The machine learning-powered platform analyzes gene expression data from biopsies to provide molecular scores for rejection probability and tissue injury.
The machine learning-powered platform analyzes gene expression data from biopsies to provide molecular scores for rejection probability and tissue injury.
The joint consensus recommendation from AMP, ASCO, and CAP addresses variability in molecular profiling report formats across laboratories.
The optimized protocols on SPT Labtech's firefly+ platform use Agilent's SureSelect Max DNA Library Prep Kit for clinical research and precision medicine applications.
The four-level quality control product features procalcitonin in liquid format and automation-compatible configurations.
The automated system uses ion exchange HPLC technology to deliver A1c results while detecting common hemoglobin variants.